14Jul
Japan Tightens Foreign Direct Investment Regulations on Life Science Companies - Prior notification requirements under the Japanese regulations were expanded to cover investments in life science companies.
On June 15, 2020, the Japanese government implemented new regulations that designate the manufacture of pharmaceuticals for infectious diseases and the manufacture of highly-controlled medical devices (medical devices that are classified as Class III or Class IV in Japan, such as a heart–lung machines and ventilators) as both "Designated Businesses" and "Core Businesses" under the Foreign Exchange and Foreign Trade Act of Japan ("FEFTA"). The new regulations were adopted in light of the COVID-19...
By:
Jones Day
Related
On September 3, 2020, the DOJ’s Antitrust Division released its Merger Remedies Manual. The manual ...
Read More >
The Setting Every Community Up for Retirement Act of 2019, or "Secure Act", has been passed by Congr...
Read More >
In recent years, fintech has been an attractive sector for growth capital, as evidenced by robust in...
Read More >
Dentist Office Fired Receptionist After Learning of Her Pregnancy, Federal Agency Charged - DALLAS...
Read More >
While the United States and California legal worlds remain (understandably) focused on issues arisin...
Read More >
More and more, I have noticed employees are recording their employers. Smartphones, along with other...
Read More >